Previous reports demonstrated that chemerin binding to CMKLR1 was involved in atherosclerosis, rheumatoid arthritis, and inflammatory bowel disease (IBD) by mediating inflammatory responses [14–21]. Here, CMKLR1 is linked to inflammatory bowel disease.